Glymphatic MRI in idiopathic normal pressure hydrocephalus
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The glymphatic system has in previous studies been shown as fundamental to clearance of waste metabolites from the brain interstitial space, and is proposed to be instrumental in normal ageing and brain pathology such as Alzheimer's disease and brain trauma. Assessment of glymphatic function using magnetic resonance imaging with intrathecal contrast agent as a cerebrospinal fluid tracer has so far been limited to rodents. We aimed to image cerebrospinal fluid flow characteristics and glymphatic function in humans, and applied the methodology in a prospective study of 15 idiopathic normal pressure hydrocephalus patients (mean age 71.3 ± 8.1 years, three female and 12 male) and eight reference subjects (mean age 41.1 + 13.0 years, six female and two male) with suspected cerebrospinal fluid leakage (seven) and intracranial cyst (one). The imaging protocol included T1-weighted magnetic resonance imaging with equal sequence parameters before and at multiple time points through 24 h after intrathecal injection of the contrast agent gadobutrol at the lumbar level. All study subjects were kept in the supine position between examinations during the first day. Gadobutrol enhancement was measured at all imaging time points from regions of interest placed at predefined locations in brain parenchyma, the subarachnoid and intraventricular space, and inside the sagittal sinus. Parameters demonstrating gadobutrol enhancement and clearance in different locations were compared between idiopathic normal pressure hydrocephalus and reference subjects. A characteristic flow pattern in idiopathic normal hydrocephalus was ventricular reflux of gadobutrol from the subarachnoid space followed by transependymal gadobutrol migration. At the brain surfaces, gadobutrol propagated antegradely along large leptomeningeal arteries in all study subjects, and preceded glymphatic enhancement in adjacent brain tissue, indicating a pivotal role of intracranial pulsations for glymphatic function. In idiopathic normal pressure hydrocephalus, we found delayed enhancement (P < 0.05) and decreased clearance of gadobutrol (P < 0.05) at the Sylvian fissure. Parenchymal (glymphatic) enhancement peaked overnight in both study groups, possibly indicating a crucial role of sleep, and was larger in normal pressure hydrocephalus patients (P < 0.05 at inferior frontal gyrus). We interpret decreased gadobutrol clearance from the subarachnoid space, along with persisting enhancement in brain parenchyma, as signs of reduced glymphatic clearance in idiopathic normal hydrocephalus, and hypothesize that reduced glymphatic function is instrumental for dementia in this disease. The study shows promise for glymphatic magnetic resonance imaging as a method to assess human brain metabolic function and renders a potential for contrast enhanced brain extravascular space imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, literature reporting human in vivo CSF tracer studies is lacking, and observations made in animals have not been translated into humans.”
From Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. (2018) · cites this paper as [13]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The accumulation of low molecular weight CSF contrast agents (< 1 kDa) supports the notion that much larger proteins also get trapped in the tortuous extracellular spaces of deep brain regions.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These various processes are linked in their regulation by the brain’s glymphatic system, whose directed regulation in turn may present bold new therapeutic opportunities for the disease-modifying treatment of patients with these disorders (75).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous observations indicate no measurable enhancement of contrast agent at MRI in the REF location after intrathecal injection of gadobutrol at this concentration (13).”
From Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. (2018) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The contrast agent remains trapped in the same regions for prolonged periods of time, especially if an underlying pathology is present (74, 75).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [75]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824 · cited 6×
“REF = reference subject; SU = signal unit. subarachnoid space (Iliff et al., 2012, 2013a; Bedussi et al., 2017), but contradictory to studies where intraparenchymal injection of tracers has been used (Carare et al., 2008; Bakker et al., 2016), where it was concluded with retrograde flow.”
BackgroundResultInfluentialSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 3×
“Glymphatic transport of solutes is highly dependent on sleep (Xie et al., 2013) and body posture (Lee et al.”
BackgroundStructural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075 · cited 1×
“By administration of an intrathecal contrast agent at the lumbar level, ‘glymphatic MRI’ may thereby bridge the gap from animal studies to investigations of glymphatic clearance of solutes from the human brain interstitial space (Jessen et al., 2015).”
BackgroundClearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521 · cited 3×
“It can therefore not be established to what degree iNPH disease or age/gender contributed to differences between groups, while reduced glymphatic function should be expected with normal ageing (Kress et al., 2014).”
BackgroundSymptomatic Occult Hydrocephalus with Normal Cerebrospinal-Fluid Pressure: A Treatable Syndrome
Adams, R. D., Fisher, C. M., Hakim, S., Ojemann, R. G., & Sweet, W. H. (1965) · New England Journal of Medicine · doi:10.1056/nejm196507152730301 · Cited by 1,370 · cited 1×
“INPH is a neurodegenerative disease with a typical symptom triad of gait ataxia, urinary incontinence and dementia and can be treated surgically with CSF diversion procedures (Adams et al., 1965).”
BackgroundCerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., & Nedergaard, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-13.2013 · Cited by 1,319 · cited 6×
“REF = reference subject; SU = signal unit. subarachnoid space (Iliff et al., 2012, 2013a; Bedussi et al., 2017), but contradictory to studies where intraparenchymal injection of tracers has been used (Carare et al., 2008; Bakker et al., 2016), where it was concluded with retrograde flow.”
BackgroundMethodResultInfluentialBrain-wide pathway for waste clearance captured by contrast-enhanced MRI
Iliff, J. J., Lee, H., Yu, M., Feng, T., Logan, J., Nedergaard, M., & Benveniste, H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67677 · Cited by 1,148 · cited 6×
“REF = reference subject; SU = signal unit. subarachnoid space (Iliff et al., 2012, 2013a; Bedussi et al., 2017), but contradictory to studies where intraparenchymal injection of tracers has been used (Carare et al., 2008; Bakker et al., 2016), where it was concluded with retrograde flow.”
BackgroundMethodResultInfluentialSymptomatic occult hydrocephalus with "normal cerebrospinal fluid pressure".
Bh, M. (1970) · PubMed · Cited by 1,035
Research works printed but not linked: 1
- Cheng, 2004, Gadobutrol. Molecular Imaging and Contrast Agent Database (MICAD)
Cited by
Items 701–771 of 771
Small vessel disease: what it is and how to assess it
Humphreys, C. A., & Smith, C. T. (2026) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2026.03.001
Astrocyte dysfunction in hydrocephalus: Neuroinflammation and glymphatic impairment
Deng, X., Zhang, C., Huang, K., Duan, Q., Li, G., Liu, X., Ge, H., Sun, R., Zhao, L., & Zhou, L. E. T. A. O. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115790
Connections across regional glymphatic clearance, neural activity and amyloid-β deposition in cortexPreprint
Li, Y., Zhu, X., Zhou, Y., Zhang, X., Zhou, Z., Wei, K., Sun, J., & Lou, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720377
“Employing Glymphatic MRI by intrathecal administration of gadolinium-based contrast agents 11 , we quantified spatiotemporally resolved CSF dynamics across cortex.”
Κέδρας, Θ. Ν. (2026) · University of Thessaly Institutional Repository (University of Thessaly)
Hernes, S. S., Nordnes, P. R., Hol, H. R., Ringstad, G. A., A.-B., K., Emhjellen, P. E., Lohaugen, G., Emini, M., & Edwin, T. H. (2026) · Trials · doi:10.1186/s13063-026-09711-6
Self-citationStagnation and Progression: How Glymphatic Failure Promotes Meningioma Malignancy in Aging
Zhou, W., 魏乃礼, Xu, F., Li, C., Deng, R., Yu, Y., Qiu, Y., Lv, Y., Meng, H., Lu, J., et al. (2026) · Aging and Disease · doi:10.14336/ad.2026.0116
田, 佳. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651857
Özpar, R., Ocak, P. E., Bekâr, A., & Hakyemez, B. (2026) · Diagnostic and Interventional Radiology · doi:10.4274/dir.2026.263987
Post-gadolinium T1 alterations in Parkinson's disease and essential tremor
Kim, J., Jeong, E., Choi, Y., Nam, Y., Kim, H. S., Jo, S., & Chung, S. J. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01390-z
Meningeal CSF transport varies across parasagittal dura subregions with age in humans
Malis, V., Jung, H. N., Kuwatsuru, Y., Bae, W. C., & Miyazaki, M. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261455452
“2), parasagittal dura (3), superior sagittal sinus (4), arachnoid granulations (5), meningeal lymphatic vessels (6), subarachnoid space (7), gray matter (8), and white matter (9).”
The electrofluidic brain as a basement layer for neural computation
Chakravarthy, V. S., Chandrasekaran, V., & Shanbhag, N. C. (2026) · Communications Biology · doi:10.1038/s42003-026-10444-0
“…functionthatmoderntechnologiesareonlynowbeginningtocon fi rm and re fi ne. Recent translational approaches propose tracking intrathecally administered contrast agents (e.g., gadolinium) via blood and/or urine to non-invasivelyinferglymphaticclearance 99,100,141 .”
Uthayasuriyan, N., Gowthaman, S. R., Pachiyappan, J., Damodaran, A. C., & Ali, M. N. H. (2026) · BMC Neurology · doi:10.1186/s12883-026-05087-x
“However, the relationship between glymphatic pathways and ventricular PCNSL remains speculative and requires further investigation [25–28].”
Eide, P. K., & Lashkarivand, A. (2026) · Acta Neurochirurgica · doi:10.1007/s00701-026-06973-6
“Retrograde CSF flow from the subarachnoid space into the ventricles has been demonstrated using intrathecal tracer studies and may explain this characteristic distribution of intraventricular blood [22].”
Self-citationGlymphatic system dysfunction and neurological disorders: From mechanisms to therapeutic strategies
Guo, Z., Dai, M., Song, S., Ning, C., Li, Z. Y., Tian, H., & Dong, J. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261458981
Bridging veins govern discrepancy of CSF efflux into dura mater in mice
Yan, L., Satyanarayanan, S. K., Huang, D., Qin, Y., Wu, D., Lai, J., Qin, D., & Su, H. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20252556
Hohenhaus, M., Urbach, H., Schröter, N., Reisert, M., Demerath, T., Shah, M. S. A., Hosp, J. A., Beck, J., & Rau, A. (2026) · Neuroradiology · doi:10.1007/s00234-026-04106-5
Alan, B. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s603749
“7,20,21 In addition, abnormal changes in both peripheral and central chemoreflexes occur in HF patients, leading to sympathetic and parasympathetic activation.”
Connections across regional glymphatic clearance, neural activity and amyloid-β deposition in cortexPreprint
Li, Y., Zhu, X., Zhou, Y., Zhang, X., Zhou, Z., Wei, K., Sun, J., & Lou, M. (2026) · eLife · doi:10.7554/elife.111724.1
Connections across regional glymphatic clearance, neural activity and amyloid-β deposition in cortexPreprint
Li, Y., Zhu, X., Zhou, Y., Zhang, X., Zhou, Z., Wei, K., Sun, J., & Lou, M. (2026) · eLife · doi:10.7554/elife.111724
Progress in imaging techniques applied to the study of the glymphatic system
Wang, W., Zhang, Z. Q., Wang, H., Shu, J., Jin, H., & Sun, W. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.024
The glymphatic system and Parkinson’s disease: a narrative review
Acaroğlu, M. A., Abdelghaffar, T., Samancı, B., Zirh, A. T., Samancı, Y., & Yılmaz, N. H. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09291-y
“Notably, similar diffusion-based signatures have been reported in Alzheimer’s disease and iNPH, where reduced ALPS indices and increased PVS burden are linked to cortical atrophy, cognitive decline, and ventriculomegaly [63, 64, 76].”
Poniatowski, Ł. A., Eske-Pogodda, K., Siwińska, A., Olczak, M., Meinck, K., & Fritsch, M. J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15156129
“…significance. iNPH has been linked to altered pulsatility, reduced clearance of metabolites, periventricular ischemic susceptibility, and ependymal dysfunction, where all of these could contribute to a microenvironment in which immunometabolic compensation becomes chronically engaged [40,41].”
Phillips, W. T., & Schwartz, J. G. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1897376
“Direct assessment of glymphatic function has historically relied on the intrathecal administration of magnetic resonance imaging (MRI) contrast agents, followed by serial imaging to track brain clearance (Ringstad et al., 2017; Klostranec et al., 2021).”
Girelli, A., Solheim, A., Lian, S. L., Storås, T. H., Nordengen, K., & Mardal, K. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00861-y
Vazquez, S. M., Sanikommu, S., Lu, V. M., & Buckley, R. T. (2026) · Neurosurgical Review · doi:10.1007/s10143-026-04443-2
“† Other includes countries contributing a single trial: Finland, Ukraine, Turkey, Netherlands, Japan, Portugal, Denmark, Norway, and Iran mirrors broader progress in neuroscience, imaging, and medical device development, which have broadened the scope of investigational methods [ 8 , 9, 36, 44 ].”
InfluentialLi, L., Ding, G., Zhang, L., Luo, H., Boyd, E., Li, Q., Kaur, J., Bohara, M., Chopp, M., Zhang, Z. G., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1788077
“…are also needed to obtain the temporal profiles of both tracer infusion and tracer clearance, which take at least over 24-h’ time span for human brain after intrathecal tracer injection (Ringstad et al., 2017; Ringstad et al., 2018; Yamamoto et al., 2024) and cannot be translated to the clinic.”
Schipper, M. R., van Harten, T. W., Koemans, E. A., Goeman, J. J., Wermer, M. J. H., van Osch, M. J. P., & van Walderveen, M. A. A. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261482016
Wu, X., Du, B., Chen, Q., Hang, R., Cui, C., & Li, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1931370
Cognitive profiles in idiopathic normal pressure hydrocephalus and Alzheimer's disease
Dejgaard, M. S., Eide, P. K., Tangen, G. G., Skovlund, E., Selbæk, G., & Wyller, T. B. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261478264
“3,20 Patient inclusion and clinical assessment have previously been described.”
Self-citationWu, J., Meng, X., Han, C., Sun, Y., Wen, K., Li, K., Zhang, Y., & Wang, X. (2026) · Burns & Trauma · doi:10.1093/burnst/tkag048
Xiao, Y., Xie, X., Chen, S., Luo, D., Deng, X., Li, X., Yi, J., Dai, J., Zhao, H., & Xiao, X. (2026) · Academic Radiology · doi:10.1016/j.acra.2026.07.051
Li, H., Wang, M., Yang, B., Liu, X., Li, W., Fu, F., & Liu, J. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00873-8
Sacchi, L., Veronesi, V., Bocca, G., Schmid, L., D’Agata, F., Campisi, C., Örzsik, B., Arcaro, M., Fenoglio, C., Carandini, T., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261467934
Solheim, A., Ringstad, G. A., Eide, P. K., Rognes, M. E., Acar, E., & Mardal, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.14.750103
“Parts of the dataset have been included in previous studies of human glymphatic function conducted at the University Hospital of Oslo (Ringstad et al., 2017, 2018) in the years 2015–2019.”
InfluentialSelf-citationGlymphatic System Research in Neurosurgery: A Bibliometric and Co-Word Network Analysis (2015–2026)
Şahin, Ö. S. (2026) · Lokman Hekim Health Sciences · doi:10.14744/lhhs.2026.03243
Raihane, A. S., Napoli, M. D., Bragin, D. E., Cáceres, E. L., Ortiz, M. M., Moore, M. N., & Divani, A. A. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01521-2
“Intrathecal contrast MRI shows that tracers can enter human brain tissue through CSF-con - tiguous pathways and clear over hours to days [34, 35], but this does not provide a direct species-equivalent measure of rodent glymphatic efficiency.”
InfluentialHigh‐Resolution IVIM MRI Characterizes Diffusion–Perfusion Properties of the Parasagittal Dura
Liu, Y., Liao, C.-H., Peng, S., Lin, S., Lin, C., Lin, C., Hsieh, C.-H., Chen, C., & Chang, H. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70402
“These approaches have demonstrated impaired glym-phatic transport in idiopathic normal pressure hydrocephalus, subarachnoid hemorrhage, acute ischemic stroke, and cerebral small vessel disease, as reflected by delayed clearance and prolonged tracer retention or enhancement [36–40].”
Dynamic 18F-FDG PET characterizes age-related changes in fitted ventricular FDG kinetics in humans
Zhou, Z., Zhao, T., Wang, H., Benites, A. C., Gardus, J. D., Wen, Q., Feng, Y., DeLorenzo, C., Parsey, R. V., & Huang, C. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1395
“PC-MRI provides valuable velocity-based measures of pulsa-tile CSF flow but is less suited to slow, multidirectional solute transport within the ventricular system ( Ringstad et al., 2017).”
Zhou, Y., Pan, X., Xia, Z., Sha, Y., Sun, G., Han, F., Yao, M., Zhou, L., Tu, L., Feng, F., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1933808
Voumvourakis, K. I., Τhomaidis, Ν. S., Sideri, E., Papadimitropoulos, G. N., Liadinioti, C., Tsivgoulis, G. K., & Tsiodras, S. (2026) · Biomedicines · doi:10.3390/biomedicines14102178
“Clearance of gadobutrol has been reported to be delayed in iNPH patients compared to healthy individuals, showing increased persistence in the brain parenchyma [77–79].”
Korhonen, V. E. (2024) · UEF eRepo (University of Eastern Finland)
Räsänen, J. (2025) · UEF eRepo (University of Eastern Finland)
Cerebrospinal fluid biomarkers of Alzheimer’s disease in idiopathic normal pressure hydrocephalus
Vanninen, A. (2025) · UEF eRepo (University of Eastern Finland)
Dhawane, S. P. (2022) · International Journal of Pharmaceutical and Biological Science Archive
Cacciaguerra, L. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Saidovich, E. S., Бахроновна, А. Ш., & Umidovna, I. S. (2025) · American Journal of Pediatric Medicine and Health Sciences (2993-2149)
Sato, S. D., Richmond, S. B., Fling, B. W., & Seidler, R. D. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107958
Deane, A. (2025) · Otago University Research Archive (University of Otago)
김재일, Jeong, S. Y., Lee, S.-W., Yoon, U., & Kang, K. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1914240
Petraikin, A. V., Валерьевна, А. А., Vladzymyrskyy, A. V., Vasilev, Y. A., Соколова, М. В., Turkin, A. M., Melnikova-Pitskhelauri, T. V., & Kremneva, E. I. (2026) · Журнал "Диагностическая и интервенционная радиология" · doi:10.25512/dir.2026.20.2.01
Yamahara, N., & Shimohata, T. (2026) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-002283
Zheng, C., Ren, B., Wang, J., Guo, Q., Xie, Z., Li, S., Ye, D., Wang, H., & Zheng, W. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102542
Multiple target strategies in Alzheimer's disease therapy
Ma, X., Sun, H., & Ye, J. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.10.018
Chatani, S., Oki, T., Watase, S., Roberts, N., & Watanabe, Y. (2026) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2026-0048
Takase, H. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261502848
Glymphatic and lymphatic systems
Kim, M., Kim, J.-H., & Park, S.-H. (2026) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-21425-7.00018-x
Ringstad, G. A. (2026) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-21425-7.00016-6
Self-citationNeurovascular-immune-clearance remodeling in brain aging
Liu, Y., Yang, R., & Chang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1950144
Beyond BBB permeability: spatial and dynamic post-BBB barriers governing CNS drug action
Nakata, N. A., Kurita, M., Ohashi, A., Matsumoto, K., Miyabe, C., Murata, H., & Miyabe, Y. (2026) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2026.1957594
Yue, A., He, Q., Lu, H., Chen, Y., Hou, J., Xu, Y., Wu, L., & Chu, M. (2026) · Brain and Behavior · doi:10.1002/brb3.71892
Mahendran, G., Kirupaharan, P., Audu, D., & Blazer‐Yost, B. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.05.764703
Liu, D., Yang, K., An, J., Cheng, W., Jiang, K., Zhou, Y., Wang, Y., Zhu, S., Jia, Y., Yin, S., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1981909
Seiner, A., Burla, G. K. R., Shrestha, D., Bowen, M., Horvath, J. D., & Martin, B. A. (2022) · doi:10.3389/fnimg.2022.879098.s002
Zamani, A., Jenkins, L., Rodger, J., Gurvich, C., DPsych, & K.Wright, D. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101299
Supporting information 1 of Dysfunction of the glymphatic system in childhood absence epilepsy
Pu, W., Wei, S., Qiu, M., Chen, X., Zou, W., Ge, Y., & Qiu, W. (2023) · doi:10.3389/fnins.2023.1312676.s001
Hou, C., Ren, W., Wang, B., Fu, X., Liu, Q., Li, J., Zhang, H., Wang, W., Yang, X., Wei, P., et al. (2023) · doi:10.3389/fnmol.2023.1148179.s001
Nishida, N., Nagata, N., Shimoji, K., Jingami, N., Uemura, K., Ozaki, A., Takahashi, M., Urade, Y., Matsumoto, S., Iwasaki, K., et al. (2024) · doi:10.3389/fnagi.2024.1364325.s001
Lee, M. K., Cho, S. J., Bae, Y. J., & Kim, J.-M. (2022) · doi:10.3389/fneur.2022.827398.s002
Metadata
- Authors
- Ringstad, G., Vatnehol, S. A. S., & Eide, P. K.
- Affiliations
- Oslo University Hospital (NO)
- Corresponding author
- Eide, Per Kristian
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-18
- Volume
- 140
- Issue
- 10
- Pages
- 2691-2705
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841149
- OpenAlex
- W2750130602
- Cited by
- 722
- References
- 53
- Citations by year
- 2026: 101 · 2025: 89 · 2024: 97 · 2023: 89 · 2022: 87 · 2021: 87 · 2020: 69 · 2019: 51 · 2018: 48 · 2017: 3
- FWCI
- 22.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc)
- Funders
- University of Pennsylvania
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Neurosurgical Procedures and Complications
- Keywords
- idiopathic normal pressure hydrocephalus, glymphatic system, cerebrospinal fluid flow, gadobutrol, sleep, leptomeningeal arteries, cerebrospinal fluid leak, brain cysts, brain waste clearance
- MeSH terms
- Adult, Aged, Aged, 80 and over, Contrast Media, Female, Humans, Hydrocephalus, Normal Pressure, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Organometallic Compounds, Prospective Studies, Subarachnoid Space, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.